[go: up one dir, main page]

AU2003212195A1 - Protease screening and novel use of proteases - Google Patents

Protease screening and novel use of proteases

Info

Publication number
AU2003212195A1
AU2003212195A1 AU2003212195A AU2003212195A AU2003212195A1 AU 2003212195 A1 AU2003212195 A1 AU 2003212195A1 AU 2003212195 A AU2003212195 A AU 2003212195A AU 2003212195 A AU2003212195 A AU 2003212195A AU 2003212195 A1 AU2003212195 A1 AU 2003212195A1
Authority
AU
Australia
Prior art keywords
proteases
novel use
protease screening
protease
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212195A
Other languages
English (en)
Inventor
Hans Gunther Gassen
Martin Hils
Hans Christian Korting
Ralf Pasternack
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N Zyme Biotec GmbH
Original Assignee
Trommsdorff GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff GmbH and Co KG filed Critical Trommsdorff GmbH and Co KG
Publication of AU2003212195A1 publication Critical patent/AU2003212195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003212195A 2002-02-06 2003-02-06 Protease screening and novel use of proteases Abandoned AU2003212195A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02002706.6 2002-02-06
EP02002706 2002-02-06
US35781002P 2002-02-21 2002-02-21
US60/357,810 2002-02-21
PCT/DE2003/000342 WO2003066088A2 (fr) 2002-02-06 2003-02-06 Criblage de proteases et nouvelle utilisation de proteases

Publications (1)

Publication Number Publication Date
AU2003212195A1 true AU2003212195A1 (en) 2003-09-02

Family

ID=56290377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212195A Abandoned AU2003212195A1 (en) 2002-02-06 2003-02-06 Protease screening and novel use of proteases

Country Status (3)

Country Link
EP (1) EP1471935A2 (fr)
AU (1) AU2003212195A1 (fr)
WO (1) WO2003066088A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003209A1 (es) 2006-11-07 2008-05-09 Acambis Inc Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
WO1984002846A1 (fr) * 1983-01-21 1984-08-02 Advanced Drug Tech Onguent enzymatique
CS249311B1 (en) * 1983-09-29 1987-03-12 Jaroslava Turkova Proteolytic wound dressing
DE3661339D1 (en) * 1985-01-18 1989-01-12 Gauri Kailash Kumar Protein hydrolysates, production process and drugs containing th em
US4784653A (en) * 1987-06-22 1988-11-15 Johnson & Johnson Patient Care, Inc. Absorbent adhesive dressing
US5206026A (en) * 1988-05-24 1993-04-27 Sharik Clyde L Instantaneous delivery film
DK0456724T3 (da) * 1989-01-27 1995-10-02 Immunolytics Inc Præparat og fremgangsmåde til behandling af benign prostatisk hypertrofi
EP0498532A1 (fr) * 1991-01-10 1992-08-12 E.R. SQUIBB & SONS, INC. Poudre pour le débridement des tissus nécropés contenant une enzyme protéolytique
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
AU1939895A (en) * 1994-03-01 1995-09-18 E.R. Squibb & Sons, Inc. Enzymatic debridement compositions and methods
US20030021775A1 (en) * 2001-07-27 2003-01-30 Ramot University Authority For Applied Research & Industrial Development Ltd. Device for and method of controlled enzymatic removal and retrieval of tissue

Also Published As

Publication number Publication date
WO2003066088A2 (fr) 2003-08-14
EP1471935A2 (fr) 2004-11-03
WO2003066088A3 (fr) 2004-04-01

Similar Documents

Publication Publication Date Title
ZA200502867B (en) Methods of generating and screening for proteases with altered specificity
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
AU2003290513A1 (en) Capacitive resonators and methods of fabrication
AU2003300400A1 (en) Manufacture and operation of integrated circuit
AU2003243714A1 (en) Etoposide analogs and methods of use thereof
AU2003242004A1 (en) Polishing material and method of polishing therewith
IL165084A0 (en) Peptide compounds and their use as protease substrates
AU6536200A (en) Proteases and protease inhibitors
AU2003215052A1 (en) Proteolytic fermenter
AU2003247776A1 (en) Serine protease 16
AU2003210551A1 (en) Multiply-substituted protease variants
AU2002223316A1 (en) Detection of proteases and screening for protease inhibitors
PL1616007T3 (pl) Inhibitory proteinowe proteazy i ich wykorzystanie
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003212195A1 (en) Protease screening and novel use of proteases
AU2003292406A1 (en) Serine protease
AU2002348465A1 (en) Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
AU2002368193A1 (en) Use of proteases for decomposing allergens
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2003292861A1 (en) Activating protease of oil grains and hydrolyzing vegetable proteins
AU2003280992A1 (en) Novel proteins and use thereof
AU2003252734A1 (en) Novel serine protease
AU2001295778A1 (en) Novel cysteine proteases and uses thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2002363791A1 (en) Protease enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase